SecBot SecBot
6-K ·Filed Apr 2, 2026

ADAG

Adagene Inc.
BEARISH
Impact 7/10
Horizonimmediate Processed6mo ago SEC0001104659-26-038868
Notable filing: 6-K
Actionable Insight ▼ Bearish

The offering, priced at the 30-day VWAP, suggests management is capitalizing on recent positive clinical data reported in the 20-F. However, the immediate follow-up to the 20-F and the preliminary prospectus with a full capital raise indicates an urgent need for cash. Traders should monitor the stock's reaction to the dilution and assess whether the raised capital extends the company's runway sufficiently to reach its next major clinical milestones without further dilution.

DirectionBearish
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
ADAG ▲ +5.26% at T+60d
SHORT call ✗ call lost -5.26% · α vs SPY +8.90% · entry $3.99 → $4.20
Entry = T+0 close
Apr 2, 2026
via day close
T+1d
+8.27%
call -8.27% · α -7.79%
$4.32
settled 7mo ago
T+5d
-4.76%
call +4.76% · α +8.38%
$3.80
settled 7mo ago
T+20d
-7.77%
call +7.77% · α +17.65%
$3.68
settled 6mo ago
T+60d
+5.26%
call -5.26% · α +8.90%
$4.20
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Adagene Inc. has entered into an underwriting agreement to raise approximately $70.0 million through the public offering of 18,666,000 American Depositary Shares (ADSs) at $3.75 per ADS. The offering, priced at the 30-day volume-weighted average price, is expected to close on April 6, 2026, subject to customary conditions. This capital raise follows recent positive clinical data and is intended to fund ongoing R&D for its pipeline candidates.

Key Facts

  • Adagene is raising approximately $70.0 million through an underwritten public offering of 18,666,000 ADSs.
  • The offering price is $3.75 per ADS, which represents the 30-day volume-weighted average price (VWAP).
  • The gross proceeds are expected to be used for research and development activities on pipeline candidates like ADG126 and ADG138, and for general corporate purposes.
  • The offering is being managed by Leerink Partners and LifeSci Capital, with Lucid Capital Markets as co-manager.
  • Company officers and directors have agreed to a 60-day lock-up on their shares.
  • This offering comes just one day after the company filed its 20-F annual report and a preliminary prospectus supplement for the same offering.

Financial Impact

The company will receive approximately $70.0 million in gross proceeds from the sale of 18,666,000 ADSs at $3.75 each.

cashdilutionequity

Risk Factors

  • Significant shareholder dilution from the issuance of new shares.
  • The company's status as a Cayman Islands holding company with operations in China presents regulatory and geopolitical risks.
  • Potential for further capital raises if the $70 million is insufficient to fund operations to the next value inflection point.
  • The offering price at the 30-day VWAP may indicate the company is selling at a peak, potentially limiting near-term upside.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001104659-26-038868
Document: tm2610619d2_ex5-1.htm0001104659-26-038868
Document: tm2610619d2_6k.htm0001104659-26-038868
Document: tm2610619d2_ex8-1.htm0001104659-26-038868
Document: tm2610619d2_ex99-1.htm0001104659-26-038868
Document: 0001104659-26-038868-index-headers.html0001104659-26-038868
Document: 0001104659-26-038868-index.html0001104659-26-038868
Document: 0001104659-26-038868.txt0001104659-26-038868
16 reports for ADAG
Performance horizon
75% Hit rate @ T+60 3 of 4 directional calls Went positive at some point 4 of 6 best @ T+1▲ +8.27%Apr 1, 2026
Filters
Rows
Reports for ADAG — sortable, filterable
TypeNow
Sep 25, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$3.20awaiting T+60—$2.35 (−26.72%)
Sep 22, 2026
4w ago
6-K
BULLISH ★ 5/10
$3.23awaiting T+60—$2.35 (−27.40%)
Sep 10, 2026
6w ago
6-K
BULLISH ★ 5/10
$3.31awaiting T+60—$2.35 (−29.15%)
Sep 9, 2026
6w ago
6-K
NEUTRAL ★ 3/10
$3.27awaiting T+60—$2.35 (−28.29%)
Aug 16, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$3.83awaiting T+60—$2.35 (−38.77%)
Aug 12, 2026
10w ago
6-K
NEUTRAL ★ 5/10
$3.75awaiting T+60—$2.35 (−37.47%)
Aug 12, 2026
10w ago
Press Release
MIXED ★ 6/10
$3.75awaiting T+60—$2.35 (−37.47%)
Jul 6, 2026
16w ago
6-K
NEUTRAL ★ 3/10
$3.93 $3.21▼ −18.32%▼ −20.04%$2.35 (−40.33%)
Apr 17, 2026
27w ago
6-K
BULLISH ★ 8/10
$3.89 $3.67▼ −5.66%▼ −12.43%$2.35 (−39.72%)
Apr 2, 2026
29w ago
6-K
BEARISH ★ 7/10
$3.99 $4.20▼ −5.26%▲ +8.90%$2.35 (+41.23%)
Showing 10 of 16

US Market Status

Market Open — Closes in 4h 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 2, 2026